Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma
NCT05635734
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Glioblastoma
Interventions
DRUG:
Azeliragon 5 mg
DRUG:
Azeliragon 10 mg
DRUG:
Azeliragon 20 mg
Sponsor
Cantex Pharmaceuticals